Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Nike
NKE
|
+$631M |
| 2 |
PNC Financial Services
PNC
|
+$614M |
| 3 |
XYZ
Block, Inc.
XYZ
|
+$328M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$275M |
| 5 |
FedEx
FDX
|
+$236M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Meta Platforms (Facebook)
META
|
+$595M |
| 3 |
AbbVie
ABBV
|
+$489M |
| 4 |
Crown Castle
CCI
|
+$326M |
| 5 |
McDonald's
MCD
|
+$325M |
Sector Composition
| 1 | Technology | 20.85% |
| 2 | Consumer Discretionary | 16.57% |
| 3 | Financials | 13.84% |
| 4 | Healthcare | 12.56% |
| 5 | Communication Services | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
iShares MSCI India ETF
INDA
$9.4B
| – | – |
-75,552
| Closed | -$2.73M |
|
677
IPG Photonics
IPGP
$3.49B
| – | – |
-132,474
| Closed | -$28.4M |
|
678
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| – | – |
-19,128
| Closed | -$1.15M |
|
679
Masimo
MASI
$7.94B
| – | – |
-21,822
| Closed | -$1.85M |
|
680
Mettler-Toledo International
MTD
$26.4B
| – | – |
-972
| Closed | -$602K |
|
681
MACOM Technology Solutions
MTSI
$9.76B
| – | – |
-1,119,025
| Closed | -$36.4M |
|
682
Newell Brands
NWL
$2.55B
| – | – |
-3,097,189
| Closed | -$95.7M |
|
683
O-I Glass
OI
$2.04B
| – | – |
-40,176
| Closed | -$891K |
|
684
Occidental Petroleum
OXY
$45.3B
| – | – |
-11,576
| Closed | -$853K |
|
685
Plains GP Holdings
PAGP
$3.69B
| – | – |
-93,698
| Closed | -$2.06M |
|
686
PG&E
PCG
$34.6B
| – | – |
-712,926
| Closed | -$32M |
|
687
PepsiCo
PEP
$197B
| – | – |
-4,918
| Closed | -$590K |
|
688
Pultegroup
PHM
$27.4B
| – | – |
-53,886
| Closed | -$1.79M |
|
689
Prothena Corp
PRTA
$454M
| – | – |
-416,031
| Closed | -$15.6M |
|
690
Protagonist Therapeutics
PTGX
$3.71B
| – | – |
-100,000
| Closed | -$2.08M |
|
691
Rocket Pharmaceuticals
RCKT
$354M
| – | – |
-341,713
| Closed | -$3.57M |
|
692
RPC Inc
RES
$1.03B
| – | – |
-815,827
| Closed | -$20.8M |
|
693
Syndax Pharmaceuticals
SNDX
$1.41B
| – | – |
-531,028
| Closed | -$4.65M |
|
694
Southern Company
SO
$101B
| – | – |
-1,089,946
| Closed | -$52.4M |
|
695
Tempest Therapeutics
TPST
$47.6M
| – | – |
-748
| Closed | -$3.06M |
|
696
Tronox
TROX
$793M
| – | – |
-1,078,744
| Closed | -$22.1M |
|
697
Vera Bradley
VRA
$58.7M
| – | – |
-72,349
| Closed | -$881K |
|
698
VeriSign
VRSN
$27B
| – | – |
-5,127
| Closed | -$587K |
|
699
Vanguard Growth ETF
VUG
$189B
| – | – |
-1,659
| Closed | -$233K |
|
700
West Pharmaceutical
WST
$19B
| – | – |
-354,164
| Closed | -$34.9M |
|